KR20050043733A - 인자 ⅶ 폴리펩티드와 ｐａｉ-1 폴리펩티드를 포함하는약학적 조성물 - Google Patents

인자 ⅶ 폴리펩티드와 ｐａｉ-1 폴리펩티드를 포함하는약학적 조성물 Download PDF

Info

Publication number
KR20050043733A
KR20050043733A KR1020047006606A KR20047006606A KR20050043733A KR 20050043733 A KR20050043733 A KR 20050043733A KR 1020047006606 A KR1020047006606 A KR 1020047006606A KR 20047006606 A KR20047006606 A KR 20047006606A KR 20050043733 A KR20050043733 A KR 20050043733A
Authority
KR
South Korea
Prior art keywords
pai
factor vii
related polypeptide
factor
polypeptide
Prior art date
Application number
KR1020047006606A
Other languages
English (en)
Korean (ko)
Inventor
로즈크재어라스머스
Original Assignee
노보 노르디스크 헬스 케어 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노보 노르디스크 헬스 케어 악티엔게젤샤프트 filed Critical 노보 노르디스크 헬스 케어 악티엔게젤샤프트
Publication of KR20050043733A publication Critical patent/KR20050043733A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020047006606A 2001-11-09 2002-11-05 인자 ⅶ 폴리펩티드와 ｐａｉ-1 폴리펩티드를 포함하는약학적 조성물 KR20050043733A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101671 2001-11-09
DKPA200101671 2001-11-09

Publications (1)

Publication Number Publication Date
KR20050043733A true KR20050043733A (ko) 2005-05-11

Family

ID=8160829

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047006606A KR20050043733A (ko) 2001-11-09 2002-11-05 인자 ⅶ 폴리펩티드와 ｐａｉ-1 폴리펩티드를 포함하는약학적 조성물

Country Status (15)

Country Link
EP (1) EP1446146A1 (ja)
JP (1) JP2005510514A (ja)
KR (1) KR20050043733A (ja)
CN (1) CN1596122A (ja)
AU (1) AU2002340778B2 (ja)
BR (1) BR0213952A (ja)
CA (1) CA2464614A1 (ja)
CZ (1) CZ2004535A3 (ja)
HU (1) HUP0401959A3 (ja)
IL (1) IL161523A0 (ja)
NO (1) NO20042379L (ja)
PL (1) PL370118A1 (ja)
RU (1) RU2304980C2 (ja)
WO (1) WO2003039580A1 (ja)
ZA (1) ZA200403270B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009045412A2 (en) * 2007-10-01 2009-04-09 American Diagnostica, Inc. Methods of treatment using modified plasminogen activator inhibitor type-1 molecules
WO2020103930A1 (zh) * 2018-11-22 2020-05-28 上海科技大学 噻唑并环类化合物、其制备方法、中间体和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
DE60143292D1 (de) * 2000-05-03 2010-12-02 Novo Nordisk Healthcare Ag Varianten des menschlichen Koagulationsfaktors VII

Also Published As

Publication number Publication date
JP2005510514A (ja) 2005-04-21
RU2004117535A (ru) 2005-04-10
HUP0401959A2 (hu) 2004-12-28
IL161523A0 (en) 2004-09-27
AU2002340778B2 (en) 2007-08-02
WO2003039580A1 (en) 2003-05-15
CZ2004535A3 (cs) 2005-01-12
HUP0401959A3 (en) 2009-03-30
CN1596122A (zh) 2005-03-16
CA2464614A1 (en) 2003-05-15
BR0213952A (pt) 2004-08-31
ZA200403270B (en) 2004-11-08
RU2304980C2 (ru) 2007-08-27
NO20042379L (no) 2004-06-08
PL370118A1 (en) 2005-05-16
EP1446146A1 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
US20030125256A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
KR20030088430A (ko) 인자 ⅶ 폴리펩티드 및 인자 ⅸ 폴리펩티드의 조합 사용
US7078479B2 (en) Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
US20080069810A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides and TAFI Polypeptides
JP2005510515A (ja) Ｖｉｉ因子ポリペプチドおよびプロテインｃ阻害剤を含む薬学的組成物
JP2005526004A (ja) 第ｖｉｉ因子ポリペプチドおよびトラネキサム酸を含む薬学的組成物
US20070219135A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides and PAI-1 Polypeptide
KR20040015821A (ko) 인자 ⅶ 폴리펩티드와 인자 ⅹⅰ폴리펩티드를 포함하는약학적 조성물
JP2006510568A (ja) Ｖｉｉ因子ポリペプチドおよびイプシロン―アミノカプロン酸を含む薬学的組成物
US20030119741A1 (en) Pharmaceutical composition comprising factor VII polypeptides and aprotinin polypeptides
AU2002354846A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
US20080075709A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides And Thrombomodulin Polypeptides
US20060025336A1 (en) Pharmaceutical compositions comprising combinations of factor VII polypeptides and aprotinin polypeptides
KR20050043734A (ko) 인자 ⅶ 폴리펩티드와 인자 ⅴ 폴리펩티드를 포함하는약제적 조성물
JP2005508985A (ja) Ｖｉｉ因子ポリペプチドおよびアプロチニンポリペプチドを含む薬学的組成物
KR20050043733A (ko) 인자 ⅶ 폴리펩티드와 ｐａｉ-1 폴리펩티드를 포함하는약학적 조성물
JP2005510513A (ja) Ｖｉｉ因子ポリペプチドおよびｔａｆｉポリペプチドを含む薬学的組成物
AU2002340778A1 (en) Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides
JP2005511601A (ja) 第ｖｉｉ因子ポリペプチドおよび組織プラスミノゲン阻害剤を含む薬学的組成物
JP2005510516A (ja) Ｖｉｉ因子ポリペプチドおよびプロテインｓ阻害剤を含む薬学的組成物
JP2005515175A (ja) 第ｖｉｉ因子ポリペプチドおよびアルファ２−抗プラスミンポリペプチドを含む薬学的組成物
JP2005511600A (ja) Ｖｉｉ因子ポリペプチドおよびトロンボモジュリンポリペプチドを含む薬学的組成物

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application